These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29287588)

  • 1. Relation between duration of the prodromal phase and renal damage in ANCA-associated vasculitis.
    Houben E; Groenland SL; van der Heijden JW; Voskuyl AE; Doodeman HJ; Penne EL
    BMC Nephrol; 2017 Dec; 18(1):378. PubMed ID: 29287588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal vasculitis presenting with acute kidney injury.
    Villacorta J; Diaz-Crespo F; Acevedo M; Cavero T; Guerrero C; Praga M; Fernandez-Juarez G
    Rheumatol Int; 2017 Jun; 37(6):1035-1041. PubMed ID: 28289874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANCA associated vasculitis: experience of a tertiary care referral center.
    Chaudhry R; Bilal A; Austin A; Mehta S; Salman L; Foulke L; Feustel P; Zuckerman R; Asif A
    J Bras Nefrol; 2019; 41(1):55-64. PubMed ID: 30095143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary isomorphic red blood cells for the prediction of disease severity and renal outcomes in MPO-ANCA-associated vasculitis: a retrospective cohort study.
    Wang F; Jin Y; Zhou F; Luo L; Tang J; Huang L; Hu X; Liao Z; Jiang Y; Dengshuang L; Ge H; Sun D; Xiao G; Feng J; Li X
    J Nephrol; 2023 Nov; 36(8):2295-2304. PubMed ID: 37395920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials.
    Rahmattulla C; de Lind van Wijngaarden RA; Berden AE; Hauer HA; Floßmann O; Jayne DR; Gaskin G; Rasmussen N; Noël LH; Ferrario F; Waldherr R; Wolterbeek R; Göçeroğlu A; Pusey CD; Hagen EC; Bruijn JA; Bajema IM;
    Rheumatology (Oxford); 2015 May; 54(5):899-907. PubMed ID: 25342376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neutrophil cytoplasmic antibody-associated vasculitis with renal involvement: Analysis of 89 cases.
    Caravaca-Fontán F; Yerovi E; Delgado-Yagu E M; Galeano C; Pampa-Saico S; Tenorio MT; Liaño F
    Med Clin (Barc); 2017 Jan; 148(1):1-7. PubMed ID: 28196580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis].
    Guan N; Yao Y; Yang JY; Xiao HJ; Ding J
    Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):283-7. PubMed ID: 23927802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Negative Renal Vasculitis: Cohort Study in Korea.
    Lee SW; Yu MY; Baek SH; Ahn SY; Kim S; Na KY; Chae DW; Chin HJ
    J Korean Med Sci; 2016 Apr; 31(4):542-6. PubMed ID: 27051237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Gopaluni S; Flossmann O; Little MA; O'Hara P; Bekker P; Jayne D;
    Arthritis Rheumatol; 2019 May; 71(5):784-791. PubMed ID: 30418705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
    Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
    J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: A study of 504 cases in a single Chinese center.
    Bai YH; Li ZY; Chang DY; Chen M; Kallenberg CG; Zhao MH
    Semin Arthritis Rheum; 2018 Feb; 47(4):524-529. PubMed ID: 28917713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study.
    Titeca-Beauport D; Francois A; Lobbedez T; Guerrot D; Launay D; Vrigneaud L; Daroux M; Lebas C; Bienvenu B; Hachulla E; Diouf M; Choukroun G
    BMC Nephrol; 2018 Nov; 19(1):317. PubMed ID: 30413153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
    Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
    J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
    Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
    Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study.
    Kawamura T; Usui J; Kaneko S; Tsunoda R; Imai E; Kai H; Morito N; Saito C; Nagata M; Yamagata K
    BMC Nephrol; 2017 Nov; 18(1):337. PubMed ID: 29178888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk factors for early mortality and end-stage renal disease in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: experiences from a single center.
    Ni A; Chen L; Huang X; Ma Y; Lan L; Ren P; Wang Y; Zhu Y; Xu Y; Chen J; Han F
    Clin Exp Med; 2021 Aug; 21(3):389-397. PubMed ID: 33768341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis.
    Ford SL; Polkinghorne KR; Longano A; Dowling J; Dayan S; Kerr PG; Holdsworth SR; Kitching AR; Summers SA
    Am J Kidney Dis; 2014 Feb; 63(2):227-35. PubMed ID: 24183110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of neutrophil-to-lymphocyte ratio with all-cause mortality in Chinese patients with MPO-ANCA associated vasculitis.
    Huang L; Shen C; Zhong Y; Ooi JD; Zhou YO; Chen JB; Wu T; Meng T; Xiao Z; Lin W; Ao X; Tang R; Xiao X; Zhou Q; Xiao P
    Clin Exp Med; 2020 Aug; 20(3):401-408. PubMed ID: 32318926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression.
    de Joode AA; Sanders JS; Smid WM; Stegeman CA
    J Clin Apher; 2014 Oct; 29(5):266-72. PubMed ID: 24497412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis.
    Manenti L; Vaglio A; Gnappi E; Maggiore U; Allegri L; Allinovi M; Urban ML; Delsante M; Galetti M; Nicastro M; Pilato FP; Buzio C
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2143-51. PubMed ID: 26542163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.